Citigroup Inc Maxcyte, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Maxcyte, Inc. stock. As of the latest transaction made, Citigroup Inc holds 128,652 shares of MXCT stock, worth $564,782. This represents 0.0% of its overall portfolio holdings.

Number of Shares

128,652

Previous 79,739 61.34%

Holding current value

$564,782

Previous $312,000 60.26%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$3.68 - $5.06 $179,999 - $247,499	48,913 Added 61.34%	128,652 $500,000
Q2 2024 Aug 12, 2024	BUY	$3.63 - $5.0 $28,655 - $39,470	7,894 Added 10.99%	79,739 $312,000
Q1 2024 May 10, 2024	BUY	$3.94 - $5.38 $6,370 - $8,699	1,617 Added 2.3%	71,845 $301,000
Q4 2023 Feb 09, 2024	BUY	$2.6 - $5.24 $29,042 - $58,530	11,170 Added 18.91%	70,228 $330,000
Q3 2023 Nov 09, 2023	SELL	$3.02 - $5.1 $90,189 - $152,306	-29,864 Reduced 33.58%	59,058 $184,000
Q2 2023 Aug 10, 2023	BUY	$3.69 - $5.35 $102,700 - $148,901	27,832 Added 45.56%	88,922 $408,000
Q1 2023 May 11, 2023	SELL	$4.03 - $5.89 $1.08 Million - $1.58 Million	-268,166 Reduced 81.45%	61,090 $302,000
Q4 2022 Feb 09, 2023	SELL	$4.92 - $7.4 $2.51 Million - $3.77 Million	-509,486 Reduced 60.74%	329,256 $1.8 Million
Q3 2022 Nov 10, 2022	SELL	$4.52 - $6.51 $2.38 Million - $3.43 Million	-527,085 Reduced 38.59%	838,742 $5.43 Million
Q2 2022 Aug 10, 2022	BUY	$3.59 - $6.81 $4.69 Million - $8.91 Million	1,307,680 Added 2248.92%	1,365,827 $6.3 Million
Q1 2022 May 12, 2022	SELL	$5.26 - $10.84 $110,870 - $228,485	-21,078 Reduced 26.61%	58,147 $412,000
Q4 2021 Feb 10, 2022	BUY	$8.87 - $12.94 $242,807 - $354,219	27,374 Added 52.79%	79,225 $795,000
Q3 2021 Nov 10, 2021	BUY	$12.21 - $17.2 $633,100 - $891,837	51,851 New	51,851 $629,000

Others Institutions Holding MXCT

# of Institutions

124

Shares Held

67.1M

Call Options Held

Put Options Held

View Full List

About MAXCYTE, INC.

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $447M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

More about MXCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account